The Chairman has expressed his thanks for Dr. Sandor's outstanding contribution to the Board during his time as a director of the company. LIFFE is delighted to confirm that Dr. Sandor will continue as a director on the Board of NQLX, LIFFE's joint venture with the Nasdaq Stock Market.
FTSE Mondo Visione Exchanges Index:
LIFFE: Appointment Of New Director
Date 12/10/2001